전체 기조 강연
Tri-Tri-Conference는 질병의 증상 완화, 의료 액세스의 개선, 큰 변화를 초래하는 치료법의 발견 등에서 중요한 역할을 담당하는 분자의학, 진단, Drug Discovery, 의약품 개발 등 분야의 새로운 기술 및 연구 가능성을 판별하기 위한 플랫폼으로, 앞으로도 이 역할을 계속 담당할 전망입니다. 약 1,000여 명이 참가하는 전체 기조 강연은 각 컨퍼런스 프로그램의 참가자가 한자리에 모이는 유일한 세션으로, 컨퍼런스 기간 중 매일 진행됩니다.
3월 11일(월) 5:00 - 6:00PM
5:15 생체 시료 기부:시료를 제공한 가족과 유전자진단연구소의 생체의학 연구 진전 과정
Sarah shares the now world-famous story of how she anonymously donated her infant son’s post-mortem tissue for biomedical research to some of the most prestigious scientific facilities in the country, including the University of Pennsylvania. Years later, she tracked down each donation. She met with researchers and scientists who received the donations to learn how they are being studied in cutting-edge research for medical discoveries. One of these research scientists who received her son’s retinas is Dr. Arupa Ganguly. Dr. Ganguly directs the genetic diagnostic lab at the University of Pennsylvania and studies retinoblastoma, a childhood-onset cancer caused by mutations in tumor suppression gene. They will share their experience and perspective on biospecimen donation.
Sarah Gray, Author, A Life Everlasting: The Extraordinary Story of One Boy’s Gift to Medical Science
Arupa Ganguly, PhD, Professor of Genetics, Perelman School of Medicine, University of Pennsylvania
Speaker to be Announced, Rheonix
6:00 Grand Opening Reception in the Exhibit Hall with Poster Viewing and Book Signing*
*Book Signing with Sarah Gray, Author, A Life Everlasting: The Extraordinary Story of One Boy’s Gift to Medical Science
Book will be available for purchase onsite
3월 12일(화) 8:00 - 9:15AM
맞춤형 의료를 실현하기 위한 데이터 사이언스
Big data and machine learning have the potential to improve health, detecting disease at an earlier stage and personalizing interventions. The key ingredient, some say, is applying algorithms to population-wide datasets. But the question remains: is it enough to train smarter algorithms with broader datasets? What other approaches, diagnostics tools, and technologies do we need to accurately assess a patient’s unique needs and build a personalized intervention? A panel of experts across diagnostics, informatics, and therapeutics from government, academia, integrated health centers, data science, and biopharma will lead a highly interactive exploration of these issues and predict what it will take to realize the role of data science enabling personalized medicine.
Moderator: Marty Tenenbaum, PhD, Founder and Chairman, Cancer Commons; Prominent AI Researcher; Cancer Survivor
Tanya Cashorali, CEO, Founder, TCB Analytics
Gaurav Kaushik, Associate Director, Data Products & Strategy, Foundation Medicine, Inc.
David Smoley, CIO, AstraZeneca
Additional Speakers to be Announced
3월 13일(수) 8:00 - 10:00AM
기조 패널 디스커션：새로운 기술과 업계 전망
A popular session at Tri-Conference! This panel session will feature a series of short podium presentations on emerging and hot technologies in molecular medicine. Each speaker will have 7 minutes to present. After all speakers have presented, there will be a moderated Q&A with attendees. The presentations are not meant to be a corporate or specific product pitch. Each speaker will focus on a technology and solution framed around a motivational clinical problem and how their particular company/organization is solving it.
Kristin Ciriello Pothier, Global Head of Life Sciences Strategy, Parthenon-EY; Author, Personalizing Precision Medicine
Scott Palmer, Vice President and Head of Precision Medicine, Parthenon-EY
Speaker to be Announced, Protolife
Speaker to be Announced, iSpecimen
Speaker to be Announced, Ximedica
Joseph Krueger, CSO, Flagship Biosciences
Florian Bell, Senior Member, Technical Staff-System Integration, Qorvo Biotechnologies, LLC
Speaker to be Announced, Benchling
Speaker to be Announced, ANGLE plc
Additional Speakers to be Announced
* 주최측 사정에 따라 사전 예고없이 프로그램이 변경될 수 있습니다.